Clinical Trials Browser

Phase 1/2 × Has results × Therapeutics × Clear all

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Phase 1/2 Completed

40 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT03443635 2022-04-29

CHOP

Phase 1/2 Completed

7,192 enrolled 7 charts

Cardiovascular Diseases, Depression, Diabetes Mellitus, Hypertension, Motor Activity, Neoplasms, Nutrition Disorders, Obesity

NCT01671488 2020-02-17

276

Phase 1/2 Terminated

11 enrolled 11 charts

Gastrointestinal

Anus Neoplasms

NCT01892293 2019-01-10

CT Antigen TCR-Engineered T Cells for Myeloma

Phase 1/2 Terminated

6 enrolled 10 charts

Multiple Myeloma